Evidence map›Paper›PMID 30767215›Full record

ArticleBritish journal of pharmacology2019

Cannabinoid CB

Krista J Spiller, Guo-Hua Bi, Yi He, Ewa Galaj, Eliot L Gardner, Zheng-Xiong Xi

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Elucidating biased signaling in class A GPCRs.Trends in pharmacological sciences · 2025
    Review
  4. Article
  5. Cannabidiol alleviates methamphetamine addictionActa pharmaceutica Sinica. B · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Daily ΔBiological psychiatry global open science · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Neuropsychiatric Model of Addiction Simplified.The Psychiatric clinics of North America · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Receptor mechanisms underlying the CNS effects of cannabinoids: CBAdvances in pharmacology (San Diego, Calif.) · 2022
    Article
  20. Neuroprotective Effects of Cannabidiol but Not ΔInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Krista J SpillerDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-1980-694X
Guo-Hua BiMolecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
Yi HeMolecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
Ewa GalajMolecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
Eliot L GardnerMolecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
Zheng-Xiong XiMolecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
National Institute on Drug Abuse · USUniversity of Pennsylvania · US

Funding

Central CB2 Cannabinoid ReceptorsZIADA000620 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 2017 to 2019
$860k
6 · The paper itself

Abstract

background and purposeEndocannabinoids are critically involved in brain reward functions, mediated by activation of CB EXPERIMENTAL APPROACH: In the present study, we used the electrical intracranial self-stimulation paradigm to evaluate the effects of various cannabinoid drugs on brain reward in laboratory rats and the roles of CB KEY

resultsTwo mixed CB CONCLUSIONS AND IMPLICATIONS: CB

Indexed as

RewardAnimalsBrainCannabinoidsCannabisMaleRatsRats, Long-EvansReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2CannabinoidsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2

Identifiers

PMID30767215
PMCPMC6468271
OpenAlexW2913493885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.